Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Rebecca Aubrey Betensky, Ph.D.

Co-Author

This page shows the publications co-authored by Rebecca Betensky and Bradley Hyman.
Connection Strength

3.032
  1. Opposing Roles of apolipoprotein E in aging and neurodegeneration. Life Sci Alliance. 2019 02; 2(1).
    View in: PubMed
    Score: 0.206
  2. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A. 2018 02 06; 115(6):E1289-E1298.
    View in: PubMed
    Score: 0.191
  3. Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design. JAMA Neurol. 2017 05 01; 74(5):540-548.
    View in: PubMed
    Score: 0.182
  4. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum. J Neuropathol Exp Neurol. 2016 06; 75(6):516-26.
    View in: PubMed
    Score: 0.169
  5. Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease. Am J Pathol. 2016 Feb; 186(2):375-84.
    View in: PubMed
    Score: 0.165
  6. APOEe2 is associated with milder clinical and pathological Alzheimer disease. Ann Neurol. 2015 Jun; 77(6):917-29.
    View in: PubMed
    Score: 0.159
  7. Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses. Acta Neuropathol Commun. 2014 Jun 10; 2:63.
    View in: PubMed
    Score: 0.149
  8. Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol. 2014 Apr; 75(4):597-601.
    View in: PubMed
    Score: 0.147
  9. Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol. 2013 Dec; 72(12):1182-92.
    View in: PubMed
    Score: 0.143
  10. Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med. 2013 Nov 20; 5(212):212ra161.
    View in: PubMed
    Score: 0.143
  11. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol. 2013 Jun; 72(6):462-71.
    View in: PubMed
    Score: 0.139
  12. Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints. J Alzheimers Dis. 2013; 36(3):475-86.
    View in: PubMed
    Score: 0.135
  13. Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease. Nat Neurosci. 2012 Oct; 15(10):1422-9.
    View in: PubMed
    Score: 0.131
  14. Stable size distribution of amyloid plaques over the course of Alzheimer disease. J Neuropathol Exp Neurol. 2012 Aug; 71(8):694-701.
    View in: PubMed
    Score: 0.131
  15. Inhibition of the NFAT pathway alleviates amyloid ß neurotoxicity in a mouse model of Alzheimer's disease. J Neurosci. 2012 Feb 29; 32(9):3176-92.
    View in: PubMed
    Score: 0.127
  16. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. Am J Pathol. 2011 Sep; 179(3):1373-84.
    View in: PubMed
    Score: 0.122
  17. Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain. Neurosci Lett. 2011 Jan 10; 487(3):260-3.
    View in: PubMed
    Score: 0.116
  18. Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease. Neurology. 2021 05 11; 96(19):e2414-e2428.
    View in: PubMed
    Score: 0.060
  19. Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain. J Neurochem. 2018 10; 147(1):24-39.
    View in: PubMed
    Score: 0.050
  20. Soluble oligomeric amyloid-ß induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener. 2017 03 21; 12(1):27.
    View in: PubMed
    Score: 0.045
  21. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly. Ann Neurol. 2016 12; 80(6):846-857.
    View in: PubMed
    Score: 0.044
  22. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016 Jan; 79(1):110-9.
    View in: PubMed
    Score: 0.041
  23. The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort. Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):287-93.
    View in: PubMed
    Score: 0.041
  24. Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV. Acta Neuropathol Commun. 2014 Sep 09; 2:133.
    View in: PubMed
    Score: 0.038
  25. Anti-ApoE antibody given after plaque onset decreases Aß accumulation and improves brain function in a mouse model of Aß amyloidosis. J Neurosci. 2014 May 21; 34(21):7281-92.
    View in: PubMed
    Score: 0.037
  26. Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy. PLoS One. 2013; 8(11):e80834.
    View in: PubMed
    Score: 0.036
  27. Calcineurin activation causes retinal ganglion cell degeneration. Mol Vis. 2012; 18:2828-38.
    View in: PubMed
    Score: 0.033
  28. The SIST-M: predictive validity of a brief structured clinical dementia rating interview. Alzheimer Dis Assoc Disord. 2012 Jul-Sep; 26(3):225-31.
    View in: PubMed
    Score: 0.033
  29. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci. 2006 Jan 11; 26(2):365-71.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.